[1] Lebovitz HE.Insulin resistance: definition and conse-quences[J]. Exp Clin Endocrinol Diabetes, 2001, 109: S135–S148.
[2] Ye J.Mechanism of insulin resistance in obesity: a role of ATP[J]. Front Med, 2021, 15: 372–382.
[3] Lee SH, Park SY, Choi CS.Insulin resistance: from mechanisms to therapeutic strategies[J]. Diabetes Metab J, 2022, 46: 15–37.
[4] Czech MP.Insulin action and resistance in obesity and type 2 diabetes[J]. Nat Med, 2017, 23: 804–814.
[5] Golbidi S, Daiber A, Korac B, et al. Health benefits of fasting and caloric restriction[J]. Curr Diab Rep, 2017, 17: 1–11.
[6] Anton SD, Moehl K, Donahoo WT, et al. Flipping the metabolic switch: understanding and applying the health benefits of fasting[J]. Obesity (Silver Spring), 2018, 26: 254–268.
[7] 王萍萍,肖凌凤,于成丽,等.成人2型糖尿病患者间歇性禁食的研究进展[J].现代预防医学,2021,48:3105–3109.
[8] Harvie MN, Pegington M, Mattson MP, et al. The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a ran-domized trial in young overweight women[J]. Int J Obes (Lond), 2011,35: 714–727.
[9] Antoni R, Johnston KL, Collins AL, et al. Intermittent v. continuous energy restriction: differential effects on postprandial glucose and lipid metabolism following matched weight loss in overweight/obese participants[J]. Br J Nutr, 2018, 119: 507–516.
[10] Speakman JR, Mitchell SE.Caloric restriction[J]. Mol Aspects Med, 2011, 32: 159–221.
[11] Duszka K, Gregor A, Guillou H, et al. Peroxisome proli-ferator-activated receptors and caloric restriction- common pathways affecting metabolism, health, and lon-gevity[J]. Cells, 2020, 9: 1708.
[12] Schultze SM, Hemmings BA, Niessen M, et al. PI3K/AKT, MAPK and AMPK signalling: protein kinases in glucose homeostasis[J]. Expert Rev Mol Med, 2012, 14: e1.
[13] Senesi P, Ferrulli A, Luzi L, et al. Diabetes mellitus and cardiovascular diseases: nutraceutical interven-tions related to caloric restriction[J]. Int J Mol Sci, 2021, 22: 7772.
[14] Santoro A, Martucci M, Conte M, et al. Inflammaging, hormesis and the rationale for anti-aging strategies[J]. Ageing Res Rev, 2020, 64: 101142.
[15] Li Y, Chen Y.AMPK and autophagy[J]. Adv Exp Med Biol, 2019, 1206: 85–108.
[16] Li X.SIRT1 and energy metabolism[J]. Acta Biochim Biophys Sin (Shanghai), 2013, 45: 51–60.
[17] Yamauchi T, Nio Y, Maki T, et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions[J]. Nat Med, 2007, 13: 332–339.
[18] Kitada M, Ogura Y, Monno I, et al. Sirtuins and type 2 diabetes: role in inflammation, oxidative stress, and mitochondrial function[J]. Front Endocrinol (Lausanne), 2019, 10: 187–199.
[19] Witczak CA, Sharoff CG, Goodyear LJ.AMP-activated protein kinase in skeletal muscle: from structure and localization to its role as a master regulator of cell-ular metabolism[J]. Cell Mol Life Sci, 2008, 65: 3737–3755.
[20] Cao Y, Jiang X, Ma H, et al. SIRT1 and insul in resistance[J]. J Diabetes Complications, 2016, 30: 178–183.
[21] Saha AK, Xu XJ, Balon TW, et al. Insulin resistance due to nutrient excess: is it a consequence of AMPK downregulation?[J]. Cell cycle, 2011, 10: 3447–3451.
[22] Wullschleger S, Loewith R, Hall MN.TOR signaling in growth and metabolism[J]. Cell, 2006, 124: 471–484.
[23] Kezic A, Popovic L, Lalic K. mTOR inhibitor therapy and metabolic consequences: where do we stand?[J]. Oxid Med Cell Longev, 2018,2018:2640342.
[24] Palou A, Remesar X, Arola L, et al. Metabolic effects of short term food deprivation in the rat[J]. Horm Metab Res, 1981, 13: 326–330.
[25] Jeon SM.Regulation and function of AMPK in physiology and diseases[J]. Exp Mol Med, 2016, 48: e245–e245.
[26] Herzig S, Shaw RJ.AMPK: guardian of metabolism and mitochondrial homeostasis[J]. Nat Rev Mol Cell Biol, 2018, 19: 121–135.
[27] Chung S, Yao H, Caito S, et al. Regulation of SIRT1 in cellular functions: role of polyphenols[J]. Arch Bio-chem Biophys, 2010, 501: 79–90.
[28] Sears B, Saha AK.Dietary control of inflammation and resolution[J]. Front Nutr, 2021, 8: 709435.
[29] Shaw RJ.LKB1 and AMP‐activated protein kinase control of mTOR signalling and growth[J]. Acta Physiol (Oxf), 2009, 196: 65–80.
[30] Palou A, Remesar X, Arola L, et al. Metabolic effects of short term food deprivation in the rat[J]. Horm Metab Res, 1981, 13: 326–330.
[31] Oza M J, Laddha AP, Gaikwad AB, et al. Role of dietary modifications in the management of type 2 diabetic complications[J]. Pharmacol Res, 2021, 168: 105602.
[32] Puchalska P, Crawford PA.Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and thera-peutics[J]. Cell Metab, 2017, 25: 262–284.
[33] Volek JS, Noakes T, Phinney SD.Rethinking fat as a fuel for endurance exercise[J]. Eur J Sport Sci, 2015, 15: 13–20.
[34] Varady KA, Hellerstein MK.Do calorie restriction or alternate-day fasting regimens modulate adipose tissue physiology in a way that reduces chronic disease risk?[J]. Nutr Rev, 2008, 66: 333–342.
[35] Chen Y, Wang J, Wang Y, et al. A propolis-derived small molecule ameliorates metabolic syndrome in obese mice by targeting the CREB/CRTC2 transcriptional complex[J]. Nat Commun, 2022, 13: 246–266.
[36] Koo SH, Flechner L, Qi L, et al. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism[J]. Nature, 2005, 437: 1109–1114.
[37] Liu Y, Dentin R, Chen D, et al. A fasting inducible switch modulates gluconeogenesis via activator /coactivator exchange[J]. Nature, 2008, 456: 269–273.
[38] Purushotham A, Schug TT, Xu Q, et al. Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation[J]. Cell Metab, 2009, 9: 327–338.
[39] Boutant M, Kulkarni SS, Joffraud M, et al. SIRT1 gain of function does not mimic or enhance the adaptations to intermittent fasting[J]. Cell Rep, 2016, 14: 2068–2075.
[40] Shimazu T, Hirschey M D, Hua L, et al. SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production[J]. Cell Metab, 2010, 12: 654–661.
[41] Moro C, Bajpeyi S, Smith SR.Determinants of intra-myocellular triglyceride turnover: implications for insulin sensitivity[J]. Am J Physiol Endocrinol Metab, 2008, 294: E203–E213.
[42] 孙婧瑜,苏亚娟,董静梅.不同生理条件下CD36/LKB1/AMPK信号通路在骨骼肌脂肪酸氧化代谢调控中的作用机制研究[J].中国体育科技,2022,58:82–88.
[43] de Lange P, Farina P, Moreno M, et al. Sequential changes in the signal transduction responses of skeletal muscle following food deprivation[J]. FASEB J, 2006, 20: 2579–2581.
[44] Cantó C, Jiang LQ, Deshmukh AS, et al. Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle[J]. Cell Metab, 2010, 11: 213–219.
[45] Hoppeler H, Baum O, Lurman G, et al. Molecular mechanisms of muscle plasticity with exercise[J]. Compr Physiol, 2011, 1: 1383–412.
[46] Mattson MP.Energy intake and exercise as determinants of brain health and vulnerability to injury and disease[J]. Cell Metab, 2012, 16: 706–722.
[47] van Norren K, Rusli F, van Dijk M, et al. Behavioural changes are a major contributing factor in the reduction of sarcopenia in caloric‐restricted ageing mice[J]. J Cachexia Sarcopenia Muscle, 2015, 6: 253–268.
[48] Gotthardt JD, Verpeut JL, Yeomans BL, et al. Inter-mittent fasting promotes fat loss with lean mass reten-tion, increased hypothalamic norepinephrine content,and increased neuropeptide Y gene expression in diet-induced obese male mice[J]. Endocrinology, 2016, 157: 679–691.
[49] Palacios OM, Carmona JJ, Michan S, et al. Diet and exercise signals regulate SIRT3 and activate AMPK and PGC-1α in skeletal muscle[J]. Aging (Albany NY), 2009, 1: 771–783.
[50] Albrecht U.Timing to perfection: the biology of central and peripheral circadian clocks[J]. Neuron, 2012, 74: 246–260.
[51] Johnston JD.Physiological responses to food intake throughout the day[J]. Nutr Res Rev, 2014, 27: 107–118.
[52] Solt LA, Wang Y, Banerjee S, et al. Regulation of cir-cadian behaviour and metabolism by synthetic REV-ERB agonists[J]. Nature, 2012, 485: 62–68.
[53] Paschos GK, Ibrahim S, Song WL, et al. Obesity in mice with adipocyte-specific deletion of clock component Arntl[J]. Nat Med, 2012, 18: 1768–1777.
[54] Kalsbeek A, la Fleur S, Fliers E. Circadian control of glucose metabolism[J]. Mol Metab, 2014, 3: 372–383.
[55] Sadacca LA, Lamia KA, Delemos AS, et al. An intrinsic circadian clock of the pancreas is required for normal insulin release and glucose homeostasis in mice[J]. Diabetologia, 2011, 54: 120–124.
[56] Van Cauter E, Polonsky KS, Scheen AJ.Roles of circadian rhythmicity and sleep in human glucose regulation[J]. Endocr Rev, 1997, 18: 716–738.
[57] Sopowski MJ, Hampton SM, Ribeiro DCO, et al. Post-prandial triacylglycerol responses in simulated night and day shift: gender differences[J]. J Biol Rhythms, 2001, 16: 272–276.
[58] Scheer FAJL, Hilton MF, Mantzoros CS, et al. Adverse metabolic and cardiovascular consequences of circadian misalignment[J]. Proc Natl Acad Sci USA, 2009, 106: 4453–4458.
[59] Stenvers DJ, Scheer FAJL, Schrauwen P, et al. Circadian clocks and insulin resistance[J]. Nat Rev Endocrinol, 2019, 15: 75–89.
[60] Eckel-Mahan KL, Patel VR, De Mateo S, et al. Repro-gramming of the circadian clock by nutritional challenge
[J]. Cell, 2013, 155: 1464–1478.
[61] Kudo T, Akiyama M, Kuriyama K, et al. Night-time restric-ted feeding normalises clock genes and Pai-1 gene expre-ssion in the db/db mouse liver[J]. Diabetologia, 2004, 47: 1425–1436.
[62] Sutton EF, Beyl R, Early KS, et al. Early time-restricted feeding improves insulin sensitivity, blood pressure, and oxidative stress even without weight loss in men with prediabetes[J]. Cell Metab, 2018, 27: 1212–1221.
[63] Zhao Y, Hu X, Liu Y, et al. ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway[J]. Mol Cancer, 2017, 16: 1–12.
[64] Esposito K, Nappo F, Marfella R, et al. Inflammatory cytokine concentrations are acutely increased by hyper-glycemia in humans: role of oxidative stress[J]. Circulation, 2002, 106: 2067–2072.
[65] Kim KH, Kim YH, Son JE, et al. Intermittent fasting promotes adipose thermogenesis and metabolic homeo-stasis via VEGF-mediated alternative activation of macrophage[J]. Cell Res, 2017, 27: 1309–1326.
[66] Ottaviani E, Malagoli D, Capri M, et al. Ecoimmunology: is there any room for the neuroendocrine system?[J]. Bioessays, 2008, 30: 868–874.
[67] Cienfuegos S, Gabel K, Kalam F, et al. Effects of 4- and 6-h time-restricted feeding on weight and cardiometa-bolic health: a randomized controlled trial in adults with obesity[J].Cell Metab, 2020,32: 366–378.
[68] Dandona P, Aljada A, Bandyopadhyay A.Inflammation: the link between insulin resistance, obesity and diabetes[J]. Trends Immunol, 2004, 25: 4–7.
[69] Faris MAE, Madkour MI, Obaideen AK, et al. Effect of Ramadan diurnal fasting on visceral adiposity and serum adipokines in overweight and obese individuals[J].Diabetes Res Clin Pract,2019,153: 166–175.
[70] Lee Y, Kim Y, Lee M, et al. Time-restricted feeding restores obesity-induced alteration in adipose tissue immune cell phenotype[J]. Nutrients,2021,13: 3780.